Aluminum Oxide Berberis Vulgaris Root Bark Bos Tau

證據等級: L5

預測適應症: 0 個

Complex Multi-Component Mixture: No TxGNN Repurposing Prediction Available

One-Sentence Summary

This candidate is a nine-component mixture containing botanical extracts, animal-derived tissues, minerals, and at least one agricultural chemical, with no approved indication or DrugBank identifier on record. The TxGNN model was unable to generate any repurposing prediction for this entry — most likely because no component could be matched to the knowledge graph. Without a baseline indication or a predicted target disease, no evidence assessment is possible at this time.

Quick Overview

Item	Content
Drug / Mixture	ALUMINUM OXIDE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS OVARY; BOS TAURUS UTERUS; MAGNESIUM SULFATE; OXALIS ACETOSELLA LEAF; PENOXSULAM; URTICA URENS; VISCUM ALBUM FRUITING TOP
Original Indication	None recorded
Predicted New Indication	None — TxGNN returned no predictions
TxGNN Prediction Score	N/A
Evidence Level	L5 — model prediction not generated; no supporting studies
US Market Status	Not marketed (0 authorizations)
Number of NDAs	0
Recommended Decision	Hold

Why No Prediction Was Generated

Three structural problems prevent TxGNN from producing any output for this entry:

1. No DrugBank anchor. TxGNN traverses the DrugBank knowledge graph using a drugbank_id as the starting node. This record has drugbank_id: null, meaning no node exists to query. Without a graph node, no disease–drug path can be scored.

2. Heterogeneous and unrecognized components. The mixture spans at least four pharmacological categories:

Homeopathic botanicals — BERBERIS VULGARIS ROOT BARK, OXALIS ACETOSELLA LEAF, URTICA URENS, VISCUM ALBUM FRUITING TOP (all classic homeopathic ingredients)
Animal-derived organ preparations — BOS TAURUS OVARY, BOS TAURUS UTERUS (bovine glandular extracts)
Minerals — ALUMINUM OXIDE, MAGNESIUM SULFATE
Agricultural herbicide — PENOXSULAM (a rice-field sulfonamide herbicide; its presence in a pharmaceutical entry is anomalous and warrants data-quality review)

None of these components appear to have standard DrugBank entries that the pipeline can map.

3. No original indication to anchor the “from → to” prediction. TxGNN’s repurposing logic requires at least one established indication as a reference point. The original_indications list is empty.

⚠️ Data Quality Flag

PENOXSULAM is a registered agricultural herbicide (CAS 219714-96-2) used for broadleaf and grassy weed control in paddy rice. Its presence alongside homeopathic ingredients strongly suggests one of the following:

Scenario	Likelihood	Action
Data entry error (wrong ingredient name pasted)	High	Verify source record
Homeopathic ultra-dilution preparation (per homeopathic pharmacopoeia)	Possible	Confirm formulation class
Experimental or novel combination not yet classified	Low	Request full formulation dossier

This flag should be resolved before any further evaluation proceeds.

Safety Considerations

No safety data is available for this mixture as a whole. Individual component notes:

MAGNESIUM SULFATE (systemic): known laxative/tocolytic; high-dose IV use requires monitoring of serum magnesium, respiratory rate, and deep tendon reflexes.
PENOXSULAM (if genuinely present): classified as a pesticide; no pharmaceutical safety profile exists. Regulatory status as a drug ingredient is unclear.
VISCUM ALBUM (mistletoe): immunomodulatory lectins; potential interactions with immunosuppressants.

For all other components, refer to individual monographs and the product package insert.

Conclusion and Next Steps

Decision: Hold

Rationale: The TxGNN pipeline cannot score this candidate because no DrugBank node exists and no approved indication is on record. The mixture’s composition — particularly the presence of an agricultural herbicide — raises data integrity concerns that must be resolved before any scientific evaluation is meaningful.

To proceed, the following is needed:

Resolve PENOXSULAM flag — confirm whether this is a data entry error or an intentional (e.g., homeopathic) ingredient; correct the record if needed.
Classify the product type — determine whether this is a homeopathic combination, a glandular/organotherapy product, or another category; different regulatory and evidence frameworks apply.
Obtain or assign DrugBank IDs — map each active component to its DrugBank entry so TxGNN can run per-ingredient predictions and aggregate results.
Identify original indication — retrieve the product’s registered or intended therapeutic use as the anchor for repurposing analysis.
Retrieve package insert / prescribing information — needed to populate safety, warnings, and contraindication fields (currently all Data Gap).
Re-run the evidence pipeline — once components are correctly identified and mapped, re-execute the full TxGNN + evidence collection workflow.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.